Abeona Therapeutics Inc. sell nvestor
Start price
15.10.22
/
50%
€4.54
Target price
15.10.23
€2.00
Performance (%)
-0.88%
End price
29.10.22
€4.50
Summary
This prediction ended on 29.10.22 with a price of €4.50. The SELL prediction by nvestor for Abeona Therapeutics Inc. closed nearly unchanged from the start price. nvestor has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Abeona Therapeutics Inc. | 28.378% | 28.378% | 35.424% |
| iShares Core DAX® | 0.000% | -2.064% | 13.111% |
| iShares Nasdaq 100 | 0.626% | -2.884% | 37.744% |
| iShares Nikkei 225® | 1.568% | -5.892% | 19.592% |
| iShares S&P 500 | 0.334% | -2.281% | 27.745% |
According to nvestor what are the pros and cons of Abeona Therapeutics Inc. for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Low dividend yield expected
Bad rating
negative Cash Flow expected
Little Investments for future growth
Bad culture
Dependend from some customers or products
Increased challenges to pay loans and raise capital
Little innovation
Growths slower than the competition
high free float
Higher risks for its business
Significant cyclical dependencies
Business model of the past or high risk
Risky balance sheet
ROE lower than 10% per year
Below average Management
Few uniques
Sustainability is little important
Below average Marketposition
Little known brand
Comments by nvestor for this prediction
In the thread Abeona Therapeutics Inc. diskutieren
In the thread Trading Abeona Therapeutics Inc.
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.